3 Things About Novavax That Smart Investors Know

Between pandemic-driven price movements, a vaccine reaching widespread approval, and the standard slate of biotech risks and pitfalls, investors are bound to have dramatically varying outcomes with their Novavax (NASDAQ: NVAX) shares depending on when they bought in. Moving forward, keen investors are likely to take a different approach to the stock than people who are merely interested to jump on the bandwagon as it realizes billions in revenue from vaccine sales.

So, let's dive in and examine three things that the experts know so that you'll be as capable of profiting from this stock.

Image source: Getty Images

Source Fool.com